Ndiaye R BRCA2 Supplementary Material. Table S1 Primers used for BRCA1 coding exons PCR amplification. Table S2 Primers used for BRCA2 coding exons PCR amplification. (DOCX 26 kb
Types and number of variants detected (exome- and CAGP-wide) before and after variant filtration in ...
Frequency of variants of unknown significance and DCIS in women <â50Â years of age by gene. (DOCX ...
Sample preparation, sequencing, analysis and variant validation workflow. (TIF 2207 kb
Deleterious BRCA1/2 germline mutations in Pakistani patients with TNBC. (DOCX 24Â kb
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Pathogenic mutations in BRCA1 (NM_007294.3) and BRCA2 (NM_000059.3) genes (n = 96) detected in 398 p...
Breast cancer (BC) patients considered for the study, their age at diagnosis and the number of affec...
Age of onset of DCIS and family history details of women with two pathogenic variants in different g...
This file includes two tables regarding baseline characteristics of study participants, possibly pat...
Table S1. Mutagenic primers used for introducing the variants into plasmid pcDNA3 GAL4 DBD:BRCA1(aa ...
List with PDAVs detected in 54âBC patients located in genes linked to (hereditary) cancer and/or h...
BC patients vs. controls variant types enrichment in exome- and CAGP-wide. (XLSX 10 kb
Types and number of variants detected (exome- and CAGP-wide) before and after variant filtration in ...
Frequency of variants of unknown significance and DCIS in women <â50Â years of age by gene. (DOCX ...
Sample preparation, sequencing, analysis and variant validation workflow. (TIF 2207 kb
Deleterious BRCA1/2 germline mutations in Pakistani patients with TNBC. (DOCX 24Â kb
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Supplementary Methods. Table S1. Clinical and pathological characteristics, BRCA sequencing and MLPA...
Pathogenic mutations in BRCA1 (NM_007294.3) and BRCA2 (NM_000059.3) genes (n = 96) detected in 398 p...
Breast cancer (BC) patients considered for the study, their age at diagnosis and the number of affec...
Age of onset of DCIS and family history details of women with two pathogenic variants in different g...
This file includes two tables regarding baseline characteristics of study participants, possibly pat...
Table S1. Mutagenic primers used for introducing the variants into plasmid pcDNA3 GAL4 DBD:BRCA1(aa ...
List with PDAVs detected in 54âBC patients located in genes linked to (hereditary) cancer and/or h...
BC patients vs. controls variant types enrichment in exome- and CAGP-wide. (XLSX 10 kb
Types and number of variants detected (exome- and CAGP-wide) before and after variant filtration in ...
Frequency of variants of unknown significance and DCIS in women <â50Â years of age by gene. (DOCX ...
Sample preparation, sequencing, analysis and variant validation workflow. (TIF 2207 kb